FDA Committee take vote on possible OTC Narcan; Rebyota available to prevent CDI recurrence; Risk of maternal sepsis lowered with azithromycin; Cibinqo indication expanded; Topical treatment shows promise for hand eczema.
Please login or register first to view this content.